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Abstract
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and
serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hy-
perglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated
wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexametha-
sone and streptozotocin. ACTH (100 µg/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.)
and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of
these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats.
The wet-dog shake responses induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane
(DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treat-
ment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect
on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is
not strongly aociated with the enhanced susceptibility of 5-HT2A receptors under the condition of
hyperactivity of the HPA axis.
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everal epidemiological and clinical studies have 
indicated that patients with either type-1 or 
type-2 diabetes mellitus have a higher prevalence of 
psychiatric disorders than the general population [1],  
and hyperactivation of the hypothalamic-pituitary-
adrenal (HPA) axis has been reported in patients with 
diabetes mellitus,  especially in those with poor glyce-
mic control and ketoacidosis [2,  3].  It is well known 
that repeated administration of the adrenocortico-
tropic hormone (ACTH) or corticosteroid can readily 
produce not only psychological side eﬀ ects,  such as 
depression accompanied by anxiety,  excitement and 
sleeplessness,  but also hyperglycemia [4,  5].  
Therefore,  these reports led us to speculate that both 
HPA axis hyperactivity and hyperglycemia may be 
responsible for the psychiatric disorders that tend to 
occur in patients receiving chronic high dose steroid 
treatment or those who suﬀ er from diabetes mellitus.
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Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin 
(5-HT)2A receptor supersensitivity.  In the present study,  to investigate the eﬀ ect of hyperglycemia on 
the function of 5-HT2A receptors,  we compared the 5-HT2A receptor-mediated wet-dog shake responses 
in rats treated with adrenocorticotropic hormone (ACTH),  dexamethasone and streptozotocin.  ACTH 
(100 µg/rat per day,  s.c.),  dexamethasone (1 mg/kg per day,  s.c.) and streptozotocin (60 mg/kg,  i.p.) 
produced signiﬁ cant hyperglycemia at 14 days after the start of these treatments,  and the hyperglyce-
mia was most pronounced in the streptozotocin-treated rats.  The wet-dog shake responses induced by 
(±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI),  a 5-HT2A receptor agonist,  were signiﬁ -
cantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone.  However,  
streptozotocin-induced diabetes had no eﬀ ect on the wet-dog shake responses.  The results of the pres-
ent study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 
5-HT2A receptors under the condition of hyperactivity of the HPA axis.
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　 Serotonin (5-HT) and dopamine receptors play 
important roles in the pathophysiology of psychiatric 
disorders,  including depression.  For example,  ele-
vated numbers of 5-HT2A receptors and reduced dopa-
mine turnover have been reported in the post-mortem 
brains of suicide victims and depressed subjects [6,  
7].  In our previous studies using experimental ani-
mals,  we found that repeated ACTH treatment 
increases the wet-dog shake response induced by 
(±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane 
(DOI),  a 5-HT2A receptor agonist in rats [8ﾝ10].  
Moreover,  it has reported that chronic dexametha-
sone administration induces 5-HT2A receptor supersen-
sitivity in the rat brain [10].  However,  the relation-
ship between hyperglycemia and 5-HT2A receptor 
supersensitivity is not clear.
　 The primary aim of this study was to clarify 
whether or not hyperglycemia is related to the 
enhanced 5-HT2A receptor function under the condition 
of hyperactivity of the HPA axis induced by either 
ACTH or corticosteroid.  In the present study,  we 
investigated the eﬀ ects of repeated treatment with 
ACTH and dexamethasone on 5-HT2A receptor-medi-
ated wet-dog shake responses in the rat,  and then 
compared them to the responses in streptozotocin-
induced diabetic rats.  Furthermore,  to clarify 
whether the function of central dopaminergic recep-
tors is altered by hyperactivity of the HPA axis and 
hyperglycemia,  we also examined the eﬀ ects on dopa-
mine receptor-mediated stereotyped behavior in the 
rat.
Materials and Methods
　 Animals. Male Wistar strain rats (at 5ﾝ6 
weeks of age) were obtained from Charles River 
(Yokohama,  Japan).  All animals were housed at 2 
rats / cage (42×26×15 cm).  The animal room was 
maintained at 22±1 °C under a 12 h/12 h light/dark 
cycle with lights on from 7:00 AM.  Food and water 
were available ad libitum.  All animal experiments were 
performed in compliance with the Guidelines for 
Animal Experimentation and with the approval of the 
Committee of Animal Experimentation,  Ehime 
University School of Medicine.
　 Drugs. The following drugs were used:
Cortrosyn-Z (ACTH,  zinc hydroxide suspension of 
tetracosactide acetate; ); Daiichi-Sankyo Pharmaceu-
tical Co.  Ltd.,  Tokyo,  Japan),  dexamethasone sodium 
phosphate (Banyu Pharmaceutical Co.  Ltd.,  Tokyo,  
Japan),  streptozotocin (Sigma-Aldrich Co.,  St.  Louis,  
MO,  USA),  (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-
aminopropane (DOI; Sigma-Aldrich) and apomorphine 
hydrochloride (Sigma-Aldrich).  Streptozotocin (STZ) 
was dissolved in 0.05 M citrate buﬀ er at pH 4.5 imme-
diately before administration.  Apomorphine hydro-
chloride was dissolved in saline containing 0.1ｵ 
ascorbic acid and the solution was kept on ice in the 
dark to protect against oxidative degradation.  DOI and 
dexamethasone were dissolved in saline.  ACTH was 
injected subcutaneously to a volume of 0.2 ml/rat.  All 
other drugs were injected at a volume of 0.1 ml per 
100 g body weight.
　 DOI-induced wet-dog shake responses. All 
observations of DOI-induced wet-dog shake responses 
were performed between 10:00 AM and 2:00 PM.  
DOI-induced wet-dog shakes were observed in indi-
vidual clear polycarbonate cages (42×26×30 cm).  
Immediately after the subcutaneous administration of 
DOI (1 mg/kg),  the number of wet-dog shakes was 
recorded over a 30-min period [9].
　 Apomorphine-induced stereotyped behavior.
It is well established that stereotypy is a dopamine-
dependent behavior,  and apomorphine,  a mixed D1/D2 
dopamine receptor agonist,  causes stereotyped behav-
ior in animals [10].  The stereotyped behavior induced 
by apomorphine was observed in the individual wire 
mesh cages (20×15×15 cm) and scored.  The degree 
of stereotyped behavior was as follows: 0,  no stereo-
typed behavior; 1,  discontinuous sniﬃ  ng; 2,  continu-
ous sniﬃ  ng; 3,  continuous sniﬃ  ng and discontinuous 
licking or biting; 4 continuous sniﬃ  ng and continuous 
licking or biting.
　 Measurement of plasma corticosterone.
Blood samples for measurement of the plasma corti-
costerone levels were collected from the postcaval vein 
under ether anesthesia,  and trunk blood was then col-
lected in heparinized tubes.  The blood was centri-
fuged at 10,000 g for 15 min,  and then the plasma was 
removed and stored at －20 °C until analysis.  The 
blood was collected between 11:00 AM and 12:00 
PM.  The plasma corticosterone concentrations were 
determined using a commercially available enzyme 
immunoassay kit (Assay Designs,  Inc.,  Ann Arbor,  
MI,  USA) following the manufacturer’s instructions.
　 Experimental procedures. The animals were 
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subcutaneously administered ACTH (100 ｻg/rat),  
dexamethasone (1 mg/kg) and saline once daily for 14 
days.  The behavioral test (DOI-induced wet-dog shake 
responses and apomorphine-induced stereotyped 
behavior) was performed 24 h after the last treat-
ments.  Streptozotocin (60 mg/kg,  i.p.) was intraperi-
toneally administered 14 days before the experiments,  
and the control rats were administered the vehicle 
alone.  The blood glucose levels were determined using 
a glucose analyzer (Arkray glucocard Diameter-alpha 
GT-1661; Arkray,  Inc.,  Kyoto,  Japan).
　 Statistical analysis. The values were 
expressed as the means and S.E.M.  of each group.  
The data were analyzed using Student’s t-test.  P val-
ues of less than 0.05 were considered to be signiﬁ cant.  
We used the Statcel QC (OMS Publishing Inc.,  
Tokyo,  Japan) statistical analysis software package.
Results
　 Fig.  1 shows the chronological changes in the 
blood glucose levels with the daily administration of 
ACTH and dexamethasone or after a single injection 
of streptozotocin.  The plasma glucose levels gradually 
increased with the daily administrations of ACTH 
(100 ｻg/rat,  s.c.) and dexamethasone (1 mg/kg,  s.c.),  
and the plasma glucose levels signiﬁ cantly (p＜0.01,  
respectively) increased at 14 days in comparison to the 
saline-treated control rats.  On the other hand,  a sin-
gle injection of streptozotocin (60 mg/kg,  i.p.) 
increased the plasma glucose levels signiﬁ cantly (p＜
0.01) and markedly 2 days after the injection,  and 
thereafter hyperglycemia persisted.  The plasma cor-
ticosterone levels were not signiﬁ cantly diﬀ erent 
between the streptozotocin- and vehicle-treated control 
rats (Fig.  2).
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Fig. 1　 Chronological changes in the blood glucose levels in the 
rats treated with ACTH,  dexamethasone and streptozotocin.  ACTH 
(100 µg/rat,  s.c.) and dexamethasone (DEX,  1 mg/kg,  s.c.) were 
administered once daily for 14 days,  and streptozotocin (STZ,  
60 mg/kg,  i.p.) was administered on day 0.  Each point represents 
the mean±S.E.M.  (n＝6ﾝ10). ＊＊p＜0.01 (Student’s t-test).
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Fig. 2　　Plasma corticosterone levels in the rats treated with 
streptozotocin (STZ) and the vehicle.  Each column represents the 
mean±S.E.M.  (n＝8).
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　 The administration of apomorphine (1 mg/kg,  s.c.) 
caused a marked stereotyped behavior,  and its maxi-
mum eﬀ ect was observed at from 10ﾝ30 min after the 
apomorphine administration (Fig.  3).  ACTH,  dexa-
methasone and streptozotocin had no eﬀ ect on the time 
course of the stereotyped behavior score or the total 
score.
　 Fig.  4 shows the number of DOI-induced wet-dog 
shakes in the rats treated with ACTH,  dexametha-
sone and streptozotocin.  The number of wet-dog 
shakes signiﬁ cantly increased in the groups with 
ACTH and dexamethasone in comparison to the saline-
treated control groups.  However,  no signiﬁ cant dif-
ference was observed in the number of wet-dog shakes 
between the streptozotocin-induced diabetic rats and 
nondiabetic rats.
Discussion
　 Glucocorticoid excess results in insulin resistance 
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Fig. 3　　Stereotyped behavior induced by apomorphine in the rats treated with ACTH,  dexamethasone (DEX) and streptozotocin (STZ).  
Each point represents the mean score or total score for 1 h with S.E.M.  (n＝6ﾝ8).
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[12] by blunting insulin’s ability to suppress the 
hepatic glucose production and stimulate peripheral 
glucose utilization [13].  Glucocorticoids also have a 
direct inhibitory eﬀ ect on glucose-induced insulin 
release in ｹ-cells [14].  In a preliminary study,  we 
examined the dose-response eﬀ ect of ACTH (50ﾝ100
ｻg/rat) and dexamethasone (0.5ﾝ1 mg/kg) on blood 
glucose levels in rats.  The results showed that 14 
days of treatment with ACTH (50 ｻg/rat) or dexa-
methasone (0.5 mg/kg) did not change the blood glu-
cose levels; however,  treatment with ACTH (100
ｻg/rat) or dexamethasone (1 mg/kg) gradually 
increased the blood glucose levels.  On the other hand,  
streptozotocin (60 mg/kg,  i.p.) produced signiﬁ cant 
hyperglycemia 2 days after the injection,  and the 
hyperglycemia at 14 days after the treatment with the 
streptozotocin was markedly higher than that at 14 
days after treatment with ACTH (100 ｻg/rat,  s.c.) or 
dexamethasone (1 mg/kg,  s.c.).
　 Diabetic patients have been shown to have dis-
rupted circadian patterns of cortisol secretion,  with 
elevated cortisol levels [2].  Chan et al.  [15] 
reported that plasma ACTH and corticosterone levels 
in streptozotocin-induced diabetic rats were signiﬁ -
cantly higher (approximately 2-fold) at 8:00 AM,  but 
they were not diﬀ erent at 1:00 PM or 6:00 PM.  In 
the present study,  the diabetic and control rats 
showed the same corticosterone levels at 11:00 AM 
to 12:00 PM.  Therefore,  the disparity of results 
may be related to the diﬀ erences in the time of exper-
iment.  However,  we previously observed that the 
plasma corticosterone levels in rats following a 14-day 
chronic ACTH treatment (100 ｻg/day,  s.c.) were 
approximately 12-fold higher than those in the saline-
treated rats [8].  Therefore,  ACTH and dexametha-
sone produced a more marked HPA axis hyperactivity 
than streptozotocin.
　 Studies showing the presence of glucocorticoids 
and their binding sites in the central nervous system 
indicate that these hormones may aﬀ ect the central 
neurotransmission [16].  Both the dopaminergic brain 
systems and glucocorticoids are considered to be 
involved in certain psychopathological conditions in 
humans,  including depression [17].  Moreover,  psy-
chiatric abnormalities,  such as depression,  euphoria 
or manic psychoses have also been observed in psychi-
atrically healthy patients receiving chronic high dose 
steroid treatment for such medical disorders such as 
Addison’s disease,  rheumatoid arthritis,  asthma,  der-
matological or hematological diseases [18,  19].  
Studies using experimental animals have shown that 
glucocorticoids modulate such behavior in animals as 
the locomotor activity  [20] and stereotyped behavior 
[21].  Danilczuk et al.  [21] reported that single and 
large doses of prednisolone (4ﾝ20 mg/kg) or dexa-
methasone (4ﾝ8 mg/kg) intensiﬁ ed and prolonged the 
stereotypy induced by apomorphine or amphetamine in 
rats.  However,  in this study,  14-day administration 
of ACTH (100 ｻg/rat) and low doses of dexametha-
sone (1 mg/kg) had no eﬀ ect on apomorphine-induced 
315Hyperglycemia and 5-HT2A December 2007
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stereotyped behavior.  Therefore,  the discrepancy in 
our results may be related to the diﬀ erences in the 
dose of ACTH or dexamethasone.
　 The disparity of results may also be related to the 
diﬀ erences in the treatment period.  Lim et al.  [22] 
observed a decrease in the turnover of dopamine and 
an increase in the maximum binding number of dopa-
mine D2 receptors 4 weeks after a single administra-
tion of streptozotocin in the striatum of diabetic rats,  
thus suggesting that the upregulation of dopamine 
receptors might be due to decreased dopamine metab-
olism.  An in vivo brain microdialysis study has also 
shown that the basal release of dopamine and dihy-
droxyphenylacetic acid (DOPAC) in the rat ventral 
striatum was lower in diabetic than in normal rats 
[23].  However,  Sumiyoshi et al.  [24] reported that 
4 weeks after a single administration of streptozoto-
cin,  there was no change in the dopamine D2 receptor 
density in the rat striatum.  In this study,  apomor-
phine-induced stereotyped behavior was not aﬀ ected 2 
weeks after the treatment with streptozotocin.
　 The systemic administration,  as well as the micro-
injection of DOI,  a 5-HT2A/2C receptor agonist,  into 
the medial prefrontal cortex elicits dose-dependent 
wet-dog shake or head twitch responses [25,  26].  
These responses can be blocked by selective 5-HT2A 
receptor antagonists [25],  indicating that these 
responses are mediated by central 5-HT2A receptors.  
We have previously reported that the chronic admin-
istration of ACTH (100 ｻg/rat) potentiates DOI-
induced wet-dog shaking behavior in rats [9,  27].  
Similarly,  the glucocorticoid analog dexamethasone 
(1 mg/kg) has been reported to enhance DOI-induced 
wet-dog shaking behavior in rats [28].  These treat-
ments with ACTH and dexamethasone have been 
reported to increase the binding of [3H] ketanserin to 
5-HT2A receptors in the forebrain neocortex [29,  30].  
In this study,  we conﬁ rmed these phenomena using 
behavioral pharmacology.  On the other hand,  strepto-
zotocin-induced diabetes has been reported to cause an 
increase in the density of 5-HT2A receptors 4 weeks 
after streptozotocin treatment without aﬀ ecting dopa-
mine D2 receptors in the rat striatum [24].  In the 
present study,  the DOI-induced wet-dog shake 
responses in diabetic rats were not signiﬁ cantly 
aﬀ ected at 2 weeks after streptozotocin treatment.  
These ﬁ ndings indicated that the enhancement of 
5-HT2A receptor function in rats treated with ACTH 
or dexamethasone is more closely related to activation 
of the HPA axis than to hyperglycemia.
　 In conclusion,  our results indicated that repeated 
treatment with ACTH or dexamethasone enhanced the 
susceptibility of 5-HT2A receptors,  and this enhance-
ment was more associated with the HPA axis hyperac-
tivity than hyperglycemia.  It has been reported that 
glucocorticoids inhibit the glucose uptake in adipo-
cytes and ﬁ broblasts,  decrease local cerebral glucose 
utilization,  and inhibit glucose uptake in hippocampal 
neurons in vitro [31].  Moreover,  it has been sug-
gested that the prolonged exposure of hippocampal 
neurons to elevated glucocorticoid levels can lead to 
neurodegeneration or suppressed neurogenesis [31].  
Therefore,  further studies will be necessary to clarify 
the eﬀ ects of long-term hyperglycemia.
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